Numerous diagnostic tests based on prostate‐specific antigen (PSA) have been developed so far to improve early detection of prostate cancer; however, minimally invasive tests with better specificity and sensitivity are still needed to further improve diagnosis and risk stratification. The gene discussed is PSAT1; the disease is prostate cancer.